of several hairs and DOPA staining of hair follicles in the An oligonucleotide composed of a contiguous stretch of RNA and DNA residues has been developed to facilitate the correctreated skin of albino mice. Such RDOs might hold a promise tion of single-base mutations of episomal and chromosomal as a therapeutic method for the treatment of skin diseases. targets in mammalian cells. The design of the oligonucleotide However, the frequency of gene correction varies among different cells, indicating that cellular activities, such as reexploited the highly recombinogenic RNA-DNA hybrids and featured hairpin capped ends avoiding destruction by cellular combination and repair, may be important for gene conversion helicases or exonucleases. The RNA-DNA oligonucleotide by RDOs. As this technology becomes more widely utilized in the scientific community, it will be important to understand (RDO) was designed to correct a point mutation in the the mechanism and to optimize the design of RDOs to imtyrosinase gene and caused a permanent gene correction in mouse albino melanocytes, determined by clonal analysis at prove their efficiency and general applicability. the level of genomic sequence, protein and phenotypic change. Recently, we demonstrated correction of the tyrosinase gene